CTKB CapEx to Revenue
Cytek Biosciences Inc · CapEx to Revenue
CTKB CapEx to Revenue
Latest reported4.60%period ending
CTKB Quarterly CapEx/Revenue (1.93% → 4.60%)
Latest values, visible window
High-resolution chart · PNG
CTKB capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 4.6032% | |
| 4.9122% | |
| 1.6109% | |
| 1.2526% | |
| 3.4582% | |
| 2.0527% | |
| 1.5711% | |
| 1.5689% | |
| 2.5763% | |
| 1.3865% | |
| 2.6806% | |
| 2.9021% | |
| 2.7529% | |
| 1.3616% | |
| 13.6751% | |
| 2.7423% | |
| 3.3069% | |
| 2.2245% | |
| 3.3321% | |
| 3.805% | |
| 4.114% | |
| 2.0971% | |
| 0.663% | |
| 1.8887% | |
| 2.7278% | |
| 1.9346% |